Diabetes Clinical Trial
Official title:
The Diabetes Management Study
| Verified date | March 6, 2007 |
| Source | National Institutes of Health Clinical Center (CC) |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
This 1-year study will test the feasibility and effectiveness of a diabetes personal trainer
in helping youth with diabetes manage their treatment. It will examine how families with a
diabetic child handle the responsibilities of managing diabetes and deal with the changes
that come with managing the illness as the child grows up.
Children between 11 and 16 years of age receiving treatment for diabetes type 1 at Johns
Hopkins University Medical Center may be eligible for this study. The children must have been
diagnosed with diabetes at least 1 year before entering the study and must require insulin
treatment. One parent of each child will also participate.
On entering the study, each child and parent will be interviewed about various topics having
to do with taking care of diabetes. After the interview, the children will be randomly
assigned to one of two groups: Group 1 will receive education information about diabetes
management; Group 2 will be enrolled in a program in which they meet with a diabetes personal
trainer 6 to 7 times over 2 months for individualized instruction in planning and evaluating
their diabetes care activities. They will also keep in contact with their trainer by
telephone.
Children in Group 2 will be given a hand-held personal computer device in which they will
keep a record of all diabetes-related activities for 3 days, including insulin shots, meals
and snacks. In addition, they will wear an accelerometer, a small device that keeps track of
the amount of movement they make. At the end of each of the 3 days, the child will complete a
20- to 30-minute telephone interview reviewing the day. They will have a tape-recorded
interview about their experiences in taking care of diabetes. Their meetings with the
personal trainer also may be taped.
Children in both groups will continue to see the doctor at the clinic as they normally would.
At 2 and 6 months after starting the study, children in both groups will complete a telephone
interview about diabetes management. At 12 months they will complete an in-person interview.
| Status | Completed |
| Enrollment | 0 |
| Est. completion date | March 6, 2007 |
| Est. primary completion date | |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 11 Years to 16 Years |
| Eligibility |
- INCLUSION CRITERIA: Inclusion criteria include 1) youth diagnosed with Type 1 diabetes for a minimum of 1 year and requiring insulin treatment, 2) youth age 11-16, and 3) both youth and a parent with whom the youth lives most of the time and has primary responsibility for child's health willing to participate. EXCLUSION CRITERIA: Exclusion criteria include 1) comorbid chronic illness requiring daily medical management or psychiatric diagnosis or 2) youth or parent non-English speaking/writing. |
| Country | Name | City | State |
|---|---|---|---|
| United States | Johns Hopkins University | Baltimore | Maryland |
| United States | Mount Washington Pediatric Hospital | Baltimore | Maryland |
| Lead Sponsor | Collaborator |
|---|---|
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
United States,
Brown SA. Effects of educational interventions in diabetes care: a meta-analysis of findings. Nurs Res. 1988 Jul-Aug;37(4):223-30. Review. — View Citation
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05594446 -
Morphometric Study of the Legs and Feet of Diabetic Patients in Order to Collect Data Intended to be Used to Measure by Dynamometry the Pressures Exerted by Several Medical Compression Socks at the Level of the Forefoot
|
||
| Completed |
NCT03975309 -
DHS MIND Metabolomics
|
||
| Completed |
NCT01855399 -
Technologically Enhanced Coaching: A Program to Improve Diabetes Outcomes
|
N/A | |
| Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
| Recruiting |
NCT04984226 -
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
|
Phase 2 | |
| Recruiting |
NCT05007990 -
Caregiving Networks Across Disease Context and the Life Course
|
||
| Active, not recruiting |
NCT04420936 -
Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care for Our Program
|
N/A | |
| Recruiting |
NCT03549559 -
Imaging Histone Deacetylase in the Heart
|
N/A | |
| Completed |
NCT04903496 -
Clinical Characteristics and Disease Burden of Diabetic Patients Based on Tianjin Regional Database
|
||
| Completed |
NCT01437592 -
Investigating the Pharmacokinetic Properties of NN1250 in Healthy Chinese Subjects
|
Phase 1 | |
| Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Completed |
NCT03390179 -
Hyperglycemic Response and Steroid Administration After Surgery (DexGlySurgery)
|
||
| Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
| Recruiting |
NCT05294822 -
Autologous Regenerative Islet Transplantation for Insulin-dependent Diabetes
|
N/A | |
| Completed |
NCT04427982 -
Dance and Diabetes/Prediabetes Self-Management
|
N/A | |
| Completed |
NCT02356848 -
STEP UP to Avert Amputation in Diabetes
|
N/A | |
| Completed |
NCT03292185 -
A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese Subjects
|
Phase 1 | |
| Active, not recruiting |
NCT05477368 -
Examining the Feasibility of Prolonged Ketone Supplement Drink Consumption in Adults With Type 2 Diabetes
|
N/A | |
| Completed |
NCT04496401 -
PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus
|
Phase 4 |